CH625789A5 - - Google Patents

Download PDF

Info

Publication number
CH625789A5
CH625789A5 CH1571176A CH1571176A CH625789A5 CH 625789 A5 CH625789 A5 CH 625789A5 CH 1571176 A CH1571176 A CH 1571176A CH 1571176 A CH1571176 A CH 1571176A CH 625789 A5 CH625789 A5 CH 625789A5
Authority
CH
Switzerland
Prior art keywords
dibenzo
methyl
cyclohepten
piperidine
trifluoromethylthio
Prior art date
Application number
CH1571176A
Other languages
German (de)
English (en)
Inventor
David Carroll Remy
George Gal
Seemon Hayden Pines
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH625789A5 publication Critical patent/CH625789A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1571176A 1975-12-22 1976-12-14 CH625789A5 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/642,864 US4031223A (en) 1975-12-22 1975-12-22 Trifluoromethylthio derivatives of cyproheptadine

Publications (1)

Publication Number Publication Date
CH625789A5 true CH625789A5 (da) 1981-10-15

Family

ID=24578359

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1571176A CH625789A5 (da) 1975-12-22 1976-12-14

Country Status (9)

Country Link
US (1) US4031223A (da)
JP (1) JPS5287177A (da)
CH (1) CH625789A5 (da)
DE (1) DE2657950A1 (da)
DK (1) DK551076A (da)
FR (1) FR2336134A1 (da)
GB (1) GB1522238A (da)
NL (1) NL7613714A (da)
SE (1) SE428923B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK538979A (da) * 1979-01-02 1980-07-03 Merck & Co Inc Fremgangsmaade til fremstilling af 3-halogencyproheptadiner
EP0019797A1 (en) * 1979-05-21 1980-12-10 Merck & Co. Inc. Levorotatory and dextrorotatory enantiomers of 3-methoxycyproheptadine and analogs thereof, process for their preparation and antipsychotic pharmaceutical compositions
US4220651A (en) * 1979-05-21 1980-09-02 Merck & Co., Inc. Antipsychotic levorotatory enantiomers of 3-halocyproheptadines, analogs and derivatives
US4390436A (en) 1982-02-08 1983-06-28 S. C. Johnson & Son, Inc. Aqueous film forming lubricant useful in a method for drawing aluminum and other soft metals
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
EP1008348A4 (en) * 1997-02-27 2001-04-04 Ajinomoto Kk THROMBOLYTIC AGENT

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3851059A (en) * 1970-02-05 1974-11-26 Merck & Co Inc Method for the stimulation of appetite in patients

Also Published As

Publication number Publication date
NL7613714A (nl) 1977-06-24
US4031223A (en) 1977-06-21
FR2336134B1 (da) 1980-06-20
GB1522238A (en) 1978-08-23
DK551076A (da) 1977-06-23
FR2336134A1 (fr) 1977-07-22
SE7613797L (sv) 1977-06-23
JPS5287177A (en) 1977-07-20
DE2657950A1 (de) 1977-06-30
SE428923B (sv) 1983-08-01

Similar Documents

Publication Publication Date Title
DE2751258C2 (da)
DE2111071A1 (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen
CH625790A5 (da)
EP0189370A2 (de) Spiro-dioxolane, -dithiolane und -oxothiolane
DE3402601A1 (de) Neue pharmazeutisch aktive 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)chinolinderivate, deren herstellung und verwendung
WO1985000171A1 (en) Spiroxuccinimides, production and utilization thereof
EP0085899B1 (de) Neue Pyridobenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0085892B1 (de) Substituierte Dibenzodiazepinone, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
CH625789A5 (da)
EP0085893B1 (de) Pyridobenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2736259C2 (da)
DE2217420A1 (de) N-thienylmethyl-heterocyclen, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE1914981A1 (de) Verfahren zur Herstellung heterocyclischer Verbindungen
DE3520104A1 (de) Naphthoxazine, ihre herstellung und verwendung
DE2848926C3 (de) Derivate des 1,6,11,11a-Tetrahydro-[1,3-thiazino][3,4-b]isochinolins, ihre Herstellung und die sie enthaltenden Zusammensetzungen
DE3124086A1 (de) Heterozyklische verbindungen, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, welche diese verbindungen enthalten
AT371446B (de) Verfahren zur herstellung von neuen cis-4aphenylisochinolinderivaten und ihren saeureadditionssalzen
CH513806A (de) Verfahren zur Herstellung von tricyclischen Verbindungen
DE1695080A1 (de) Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen
AT260920B (de) Verfahren zur Herstellung von neuen Benzofuranderivaten und ihren Salzen
DE1445845C (de) 5-Phenyl-6,7-benzomorphane
AT373255B (de) Verfahren zur herstellung von neuen 5-subst.-10,11-dihydro-5h-dibenzo(a,d)-cyclohep en-5,10-iminen und von deren salzen sowie optischen isomeren
AT360537B (de) Verfahren zur herstellung neuer 1,4-dihydro- pyridinderivate
AT372962B (de) Verfahren zur herstellung von neuen 5-subst.-10,11-dihydro-5h-dibenzo(a,d)-cyclohep en-5,10-iminen und von deren salzen sowie optischen isomeren
DE2813255A1 (de) (-)-3-trifluormethylsulfonyl-cyproheptadin

Legal Events

Date Code Title Description
PL Patent ceased